Modulation of the endocrine and immune systems by well-controlled hyperthermia equipment

Biomedical Research

Volumn 28, Issue 3, 2007, Pages 119-125

  Tomiyama Miyaji, Chikako ^a,b   Watanabe, Mayumi ^a   Ohishi, Takahiko ^c   Kanda, Yasuhiro ^a   Kainuma, Eisuke ^a   Bakir, Hanaa Y ^a   Shen, Ji Wei ^a   Ren, Hong Wei ^a   Inoue, Masashi ^a   Tajima, Keiho ^a   Bai, Xue Feng ^d   Abo, Toru ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c Thercure Medical Co   (Japan)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; HLA DR ANTIGEN; HYDROCORTISONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; ENDOCRINE SYSTEM; EQUIPMENT; EXPOSURE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERTHERMIC THERAPY; IMMUNE SYSTEM; IMMUNOLOGICAL PARAMETERS; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NORMAL HUMAN; OXYGEN TENSION; PH; RECTUM TEMPERATURE; VENOUS BLOOD; VOLUNTEER;

ADRENOCORTICOTROPIC HORMONE; ADULT; B-LYMPHOCYTE SUBSETS; BLOOD CIRCULATION; BODY TEMPERATURE; CELLS, CULTURED; FEVER; GROWTH HORMONE; HLA-D ANTIGENS; HUMANS; HYDROCORTISONE; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 34547127865     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.28.119     Document Type: Article

References (23)

1. Atanackovic D, Pollok K, Faltz C, Boeters I, Jung R, Nierhaus A, Braumann KM, Hossfeld DK and Hegewisch-Becker S (2006) Patients with solid tumors treated with high-temperature whole body hyperthermia show a redistribution of naive/memory T-cell subtypes. Am J Physiol Regul Integr Comp Physiol 290, 585-594.
2. Huang YH, Haegerstrand A and Frostegard J (1996) Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity. Clin Exp Immunol 103, 61-66.
3. Ito A, Shinkai M, Honda H, Wakabayashi T, Yoshida J and Kobayashi T (2001) Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 50, 512-522.
4. Kato T, Sato Y, Takahashi S, Kawamura H, Hatakeyama K and Abo T (2004) Involvement of natural killer T cells and granulocytes in the inflammation induced by partial hepatectomy. J Hepatol 40, 285-290.
5. Kawai N, Ito A, Nakahara Y, Futakuchi M, Shirai T, Honda H, Kobayashi T and Kohri K (2005) Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats. Prostate 64, 373-381.
6. Kawamura H, Kawamura T, Kokai Y, Mori M, Matsuura A, Oya H, Honda S, Suzuki S, Weerasinghe A, Watanabe H and Abo T (1999) Expansion of extrathymic T cells as well as granulocytes in the liver and other organs of granulocyte-colony stimulating factor transgenic mice: Why they lost the ability of hybrid resistance. J Immunol 162, 5957-5964.
7. + T cells as well as NK cells against intraperitoneal tumors in mice. Cell Immunol 193, 219-225.
8. Kawamura T, Miyaji C, Toyabe S, Fukuda M, Watanabe H and Abo T (2000) Suppressive effect of anti ulcer agents on granulocytes-A role for granulocytes in gastric ulcer formation. Digest Dis Sci 45, 1786-1791.
9. Maruyama S, Minagawa M, Shimizu T, Oya H, Yamamoto S, Musha N, Abo W, Weerasinghe A, Hatakeyama K and Abo T (1999) Administration of glucocorticoids markedly increases the numbers of granulocytes and extrathymic T cells in the bone marrow. Cell Immunol 194, 28-35.
10. McCormick JK, Tripp TJ, Llera AS, Sundberg EJ, Dinges MM, Mariuzza RA and Schlievert PM (2003) Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes. J Immunol 171, 1385-1392.
11. Miyaji C, Watanabe H, Toma H, Akisaka M, Tomiyama K, Sato Y and Abo T (2000) Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Human Immunol 61, 908-916.
12. Miyazawa S, Watanabe H, Miyaji C, Hotta O and Abo T (2002) Leukocyte accumulation and changes in extra-renal organs during renal ischemia reperfusion in mice. J Lab Clin Med 139, 269-278.
13. - subsets, using Fas ligand/Fas molecules. Immunology 91, 219-226.
14. Osman Y, Kawamura T, Naito T, Takeda K, van Kaer L, Okumura K and Abo T (2000) Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur J Immunol 30, 1919-1928.
15. Ostberg JR, Patel R and Repasky EA (2000) Regulation of immune activity by mild (fever-range) whole body hyperthermia: effects on epidermal Langerhans cells. Cell Stress Chaperones 5, 458-461.
16. Sagiyama K, Tsuchida M, Kawamura H, Wang S, Li C, Bai X, Nagura T, Nozoe S and Abo T (2004) Age-related bias in function of natural killer T cells and granulocytes after stress: reciprocal association of steroid hormones and sympathetic nerves. Clin Exp Immunol 135, 56-63.
17. Shimamura K, Kawamura H, Nagura T, Kato T, Naito T, Kameyama H, Hatakeyama K and Abo T (2005) Association of NKT cells and granulocytes with liver injury after reperfusion of the portal vein. Cell Immunol 234, 31-38.
18. Sirvio J, Jolkkonen J and Pitkanen A (1987) Adenohypophyseal hormone levels during hyperthermia. Endocrinologie 25, 21-23.
19. + T cells for concanavalin A-induced hepatic injury in mice. J Immunol 159, 1537-1542.
20. Vendetti S, Cicconi R, Piselli P, Vismara D, Cassol M and Delpino, A (2000) Induction and membrane expression of heat shock proteins in heat-treated HPC-4 cells is correlated with increased resistance to LAK-mediated lysis. J Exp Clin Cancer Res 19, 329-334.
21. Vigas M, Celko J and Loska J (2000) Role of body temperature in exercise-induced growth hormone and prolactin release in non-trained and physically fit subjects. Endocr Regul 34, 175-180.
22. Watanabe H, Weerasinghe A, Miyaji C, Sekikawa H, Toyabe S, Mannor MK, Morshed SRM, Halder RC, Kobayashi J, Toma H, Sato Y, Iwai K, Matsuoka H and Abo T (2003) Expansion of unconventional T cells with natural killer markers in malaria patients. Parasitol Int 52, 61-70.
23. Zhang WG, Liu SH, Cao XM, Cheng YX, Ma XR, Yang Y and Wang YL (2005) A phase-I clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2, GM-CSF, and IL-6. Leuk Res 29, 3-9.